Nano-X Imaging Ltd. (NASDAQ: NNOX) has announced that its subsidiary, Nanox AI Ltd., has successfully optimized its medical imaging AI application framework for Intel Core Ultra processors using the Intel OpenVINO toolkit. This development is set to enable healthcare facilities to evaluate and deploy CT imaging AI applications on on-premise edge devices, ensuring that imaging data remains within their own infrastructure.
The optimization marks a significant step forward in bringing AI-enabled imaging insights closer to the point of care. By running inference on Intel Core Ultra-class hardware using OpenVINO, Nanox.AI has demonstrated that its framework is well-suited for on-premise medical imaging AI processing. This approach can reduce dependence on cloud connectivity and support deployment within existing hospital infrastructure, which is crucial for facilities that prioritize data security and low latency.
Nanox.AI solutions are designed to analyze routine CT scans to help identify findings correlated with chronic conditions involving cardiac, liver, and bone health. The ability to run these AI models locally on edge devices means that healthcare providers can obtain real-time insights without the need to transmit sensitive patient data to external servers. This not only enhances patient privacy but also accelerates the diagnostic process, potentially leading to earlier detection and intervention.
The implications of this optimization are far-reaching for the healthcare industry. With the increasing adoption of AI in medical imaging, the ability to deploy these tools on edge devices offers a practical solution for hospitals and clinics that may have limited connectivity or strict data governance policies. It also aligns with the broader trend towards decentralized healthcare, where advanced diagnostics can be performed in community settings or even at the bedside.
According to the press release, the optimized framework successfully ran inference on Intel Core Ultra-class hardware, validating the feasibility of on-premise AI processing. This could encourage more healthcare providers to integrate AI into their imaging workflows, knowing that they can maintain control over their data while benefiting from advanced analytics.
Nano-X Imaging is focused on driving the world’s transition to preventive healthcare by delivering an integrated end-to-end medical imaging and healthcare services platform. The company combines affordable imaging hardware, advanced AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care.
This latest development underscores Nanox’s commitment to expanding the reach of medical imaging beyond traditional hospital settings. By optimizing its AI framework for edge devices, Nanox is addressing key barriers to adoption, such as cost, infrastructure, and data security. The ability to deploy AI locally can also reduce the total cost of ownership for healthcare systems, as it minimizes the need for expensive cloud computing resources.
As the healthcare industry continues to evolve, the integration of AI into routine imaging workflows is becoming increasingly important. Nanox’s optimization for Intel Core Ultra processors represents a practical step towards making AI-driven diagnostics more accessible and secure. For more information, visit the full press release at https://ibn.fm/pld2S.
